These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 29754236

  • 1. Bacterial Genome Editing with CRISPR-Cas9: Taking Clostridium beijerinckii as an Example.
    Zhang ZT, Jiménez-Bonilla P, Seo SO, Lu T, Jin YS, Blaschek HP, Wang Y.
    Methods Mol Biol; 2018; 1772():297-325. PubMed ID: 29754236
    [Abstract] [Full Text] [Related]

  • 2. Bacterial Genome Editing with CRISPR-Cas9: Deletion, Integration, Single Nucleotide Modification, and Desirable "Clean" Mutant Selection in Clostridium beijerinckii as an Example.
    Wang Y, Zhang ZT, Seo SO, Lynn P, Lu T, Jin YS, Blaschek HP.
    ACS Synth Biol; 2016 Jul 15; 5(7):721-32. PubMed ID: 27115041
    [Abstract] [Full Text] [Related]

  • 3. Genome Editing in Clostridium saccharoperbutylacetonicum N1-4 with the CRISPR-Cas9 System.
    Wang S, Dong S, Wang P, Tao Y, Wang Y.
    Appl Environ Microbiol; 2017 May 15; 83(10):. PubMed ID: 28258147
    [Abstract] [Full Text] [Related]

  • 4. Making point mutations in Escherichia coli BL21 genome using the CRISPR-Cas9 system.
    Wang X, He J, Le K.
    FEMS Microbiol Lett; 2018 Jul 01; 365(14):. PubMed ID: 29596631
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Markerless genome editing in Clostridium beijerinckii using the CRISPR-Cpf1 system.
    Zhang J, Hong W, Zong W, Wang P, Wang Y.
    J Biotechnol; 2018 Oct 20; 284():27-30. PubMed ID: 30081040
    [Abstract] [Full Text] [Related]

  • 8. CRISPR-based genome editing and expression control systems in Clostridium acetobutylicum and Clostridium beijerinckii.
    Li Q, Chen J, Minton NP, Zhang Y, Wen Z, Liu J, Yang H, Zeng Z, Ren X, Yang J, Gu Y, Jiang W, Jiang Y, Yang S.
    Biotechnol J; 2016 Jul 20; 11(7):961-72. PubMed ID: 27213844
    [Abstract] [Full Text] [Related]

  • 9. Gene transcription repression in Clostridium beijerinckii using CRISPR-dCas9.
    Wang Y, Zhang ZT, Seo SO, Lynn P, Lu T, Jin YS, Blaschek HP.
    Biotechnol Bioeng; 2016 Dec 20; 113(12):2739-2743. PubMed ID: 27240718
    [Abstract] [Full Text] [Related]

  • 10. CRISPR Guide RNA Design Guidelines for Efficient Genome Editing.
    Schindele P, Wolter F, Puchta H.
    Methods Mol Biol; 2020 Dec 20; 2166():331-342. PubMed ID: 32710418
    [Abstract] [Full Text] [Related]

  • 11. CRISPR-Cas9-Guided Genome Engineering in C. elegans.
    Kim HM, Colaiácovo MP.
    Curr Protoc Mol Biol; 2016 Jul 01; 115():31.7.1-31.7.18. PubMed ID: 27366893
    [Abstract] [Full Text] [Related]

  • 12. Finally, Archaea Get Their CRISPR-Cas Toolbox.
    Gophna U, Allers T, Marchfelder A.
    Trends Microbiol; 2017 Jun 01; 25(6):430-432. PubMed ID: 28391963
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. CRISPR/Cas9 Technology in Translational Biomedicine.
    Leonova EI, Gainetdinov RR.
    Cell Physiol Biochem; 2020 Apr 17; 54(3):354-370. PubMed ID: 32298553
    [Abstract] [Full Text] [Related]

  • 17. CRISPR-gRNA Design.
    Pallarès Masmitjà M, Knödlseder N, Güell M.
    Methods Mol Biol; 2019 Apr 17; 1961():3-11. PubMed ID: 30912036
    [Abstract] [Full Text] [Related]

  • 18. Extending CRISPR-Cas9 Technology from Genome Editing to Transcriptional Engineering in the Genus Clostridium.
    Bruder MR, Pyne ME, Moo-Young M, Chung DA, Chou CP.
    Appl Environ Microbiol; 2016 Oct 15; 82(20):6109-6119. PubMed ID: 27496775
    [Abstract] [Full Text] [Related]

  • 19. CRISPR-Cas9 system-driven site-specific selection pressure on Herpes simplex virus genomes.
    Li Z, Bi Y, Xiao H, Sun L, Ren Y, Li Y, Chen C, Cun W.
    Virus Res; 2018 Jan 15; 244():286-295. PubMed ID: 28279800
    [Abstract] [Full Text] [Related]

  • 20. Development of CRISPR/Cas9 for Efficient Genome Editing in Toxoplasma gondii.
    Shen B, Brown K, Long S, Sibley LD.
    Methods Mol Biol; 2017 Jan 15; 1498():79-103. PubMed ID: 27709570
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.